1h66: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1h66.png|left|200px]] | [[Image:1h66.png|left|200px]] | ||
| Line 20: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
[[1h66]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1H66 OCA]. | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID:11587640</ref><references group="xtra"/> | <ref group="xtra">PMID:11587640</ref><ref group="xtra">PMID:10706635</ref><ref group="xtra">PMID:10917652</ref><ref group="xtra">PMID:10433694</ref><ref group="xtra">PMID:7568029</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Amzel, L M.]] | [[Category: Amzel, L M.]] | ||
| Line 33: | Line 32: | ||
[[Category: Oxidoreductase]] | [[Category: Oxidoreductase]] | ||
[[Category: Rossman fold]] | [[Category: Rossman fold]] | ||
Revision as of 23:03, 14 March 2011
CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE CO WITH 2,5-DIAZIRIDINYL-3-HYDROXYL-6-METHYL-1,4-BENZOQUINONECRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE CO WITH 2,5-DIAZIRIDINYL-3-HYDROXYL-6-METHYL-1,4-BENZOQUINONE
Template:ABSTRACT PUBMED 11587640
About this StructureAbout this Structure
1h66 is a 4 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
[xtra 1][xtra 2][xtra 3][xtra 4][xtra 5]
- ↑ Faig M, Bianchet MA, Winski S, Hargreaves R, Moody CJ, Hudnott AR, Ross D, Amzel LM. Structure-based development of anticancer drugs: complexes of NAD(P)H:quinone oxidoreductase 1 with chemotherapeutic quinones. Structure. 2001 Aug;9(8):659-67. PMID:11587640
- ↑ Faig M, Bianchet MA, Talalay P, Chen S, Winski S, Ross D, Amzel LM. Structures of recombinant human and mouse NAD(P)H:quinone oxidoreductases: species comparison and structural changes with substrate binding and release. Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3177-82. PMID:10706635 doi:http://dx.doi.org/10.1073/pnas.050585797
- ↑ Bianchet MA, Foster C, Faig M, Talalay P, Amzel LM. Structure and mechanism of cytosolic quinone reductases. Biochem Soc Trans. 1999 Aug;27(4):610-5. PMID:10917652
- ↑ Foster CE, Bianchet MA, Talalay P, Zhao Q, Amzel LM. Crystal structure of human quinone reductase type 2, a metalloflavoprotein. Biochemistry. 1999 Aug 3;38(31):9881-6. PMID:10433694 doi:http://dx.doi.org/10.1021/bi990799v
- ↑ Li R, Bianchet MA, Talalay P, Amzel LM. The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction. Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8846-50. PMID:7568029